Skip to content

13F-HR filed by Eagle Health Investments LP

Eagle Health Investments LP filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-14, with 27 holding rows worth $538,224,759.

Accession
0001172661-24-002255
Filed
2024-05-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2024

A holdings report, 27 entries on the cover page, a total value of $538,224,759 stated on the cover page (in dollars after the unit check, H1), rows summing to $538,224,759 with VALUE read as dollars as filed, 13F file number 028-20556. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NATERA INC COM632307104Stock632,714$57,868,022dollars as filed
ICON PUB LTD CO SHSG4705A100Stock149,590$50,254,761dollars as filed
ILLUMINA INC452327109COM318,754$43,771,299dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock179,499$41,234,510dollars as filed
DEXCOM INC COM252131107Stock284,918$39,518,127dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR84,590$33,304,775dollars as filed
IQVIA HLDGS INC COM46266C105Stock121,895$30,826,027dollars as filed
Danaher Corporation235851102COM113,685$28,389,418dollars as filed
INSPIRE MED SYS INC COM457730109Stock122,203$26,247,982dollars as filed
TRANSMEDICS GROUP INC89377M109COM278,655$20,603,751dollars as filed
PROCEPT BIOROBOTICS CORP COM74276L105Stock337,218$16,665,314dollars as filed
GUARDANT HEALTH INC COM40131M109Stock730,209$15,064,212dollars as filed
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock462,911$14,748,344dollars as filed
Intuitive Surgical,Inc.46120E602COM35,590$14,203,613dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM299,700$13,992,993dollars as filed
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock197,000$13,427,520dollars as filedput
SAREPTA THERAPEUTICS INC803607100COM103,256$13,367,522dollars as filed
FUSION PHARMACEUTICALS INC36118A100COM579,769$12,360,675dollars as filed
AGIOS PHARMACEUTICALS INC00847X104COM330,830$9,673,469dollars as filed
EXACT SCIENCES CORP COM30063P105Stock121,000$8,356,260dollars as filed
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock2,167,021$8,126,329dollars as filed
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock48,356$7,226,804dollars as filed
10X GENOMICS INC CL A COM88025U109Stock135,059$5,068,764dollars as filed
WEREWOLF THERAPEUTICS INC95075A107CMN700,000$4,536,000dollars as filed
VIKING THERAPEUTICS INC92686J106COM45,000$3,690,000dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR46,300$3,009,500dollars as filed
LANTHEUS HLDGS INC516544103COM43,200$2,688,768dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-24-002255this filing2024-05-14acceptance time not in the bulk data set